About SIMCR · Lausanne, Switzerland
Education & Clinical Research
Structured physician education and patient-centered clinical research from a Swiss scientific institute, organized around two core pillars.
SIMCR Academy
SIMCR Academy is the official educational arm of the institute, delivering structured, CME-certified, physician-reviewed scientific education on the endocannabinoid system and cannabinoid therapeutics.
Designed for:
- Physicians
- Scientists
- Healthcare professionals
- Medical educators
Educational Programs
The Academy delivers CME-certified programs and physician-reviewed educational modules built to clinical-teaching standards. The curriculum opens with a foundational course on the endocannabinoid system and extends into specialized modules in cannabinoid pharmacology and clinical applications, designed to equip physicians and healthcare professionals with the validated knowledge required for clinical practice.
Structured for International Scalability
Academy programs are designed from the outset as accredited, standardized modules that can be incorporated into universities, medical schools, and academic training environments. Courses are also delivered directly through the institute's online platform, so scalability is a structural feature of the Academy rather than a future ambition.
Clinical Research
SIMCR conducts patient-centered clinical research built on structured protocol design, real-world data collection, physician collaboration, and clinically relevant outcome frameworks. Patient safety and medically supervised care are foundational to every study the institute undertakes.
Research Model
SIMCR's research model centers on structured clinical investigation of full-spectrum cannabinoid extracts, designed and delivered under the supervision of physicians and research partners. Protocols are built around patient-centered outcomes, standardized cannabinoid formulations, and the generation of clinically meaningful real-world evidence. Most existing cannabinoid research has focused on isolated compounds; SIMCR's methodology is designed to address full-spectrum clinical questions within a rigorous scientific framework.
Inaugural Clinical Research Initiative
The institute's first human research protocol, investigating therapeutic applications of full-spectrum cannabinoid extracts, is the inaugural study of this broader research program. It is being developed under standard scientific and ethical review processes and under direct physician supervision, with patient safety and dignity as non-negotiable design principles.